We and others have also shown that MYC(N) promotes FA biosynthesis and aberrant activation of SREBP118 in cancer, including NB22,23, and genetic and pharmacological interference with FA biosynthesis blocks MYC-driven tumor growth18. Here, MYC is linked to neoplasm.